These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3901759)
21. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658 [TBL] [Abstract][Full Text] [Related]
22. Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis. First MR Pediatr Nephrol; 1995; 9 Suppl():S40-2. PubMed ID: 7492485 [TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis. Moroni G; Gallelli B; Quaglini S; Banfi G; Montagnino G; Messa P Transpl Int; 2010 Feb; 23(2):208-16. PubMed ID: 19793073 [TBL] [Abstract][Full Text] [Related]
24. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091 [TBL] [Abstract][Full Text] [Related]
25. Spontaneous remission of proteinuria in recurrent focal glomerulosclerosis. Reappraisal of plasma exchange treatment. Franco A; Peres R; Anaya F; Niembro E; Valderrabano Clin Nephrol; 1987 Sep; 28(3):158. PubMed ID: 3311505 [No Abstract] [Full Text] [Related]
26. Glomerular disease recurrence in second and subsequent kidney transplants. Kennedy C; Obilana A; O'Brien F; O'Kelly P; Dorman A; Denton M; Magee C; Conlon P Clin Nephrol; 2013 Jan; 79(1):31-6. PubMed ID: 23073068 [TBL] [Abstract][Full Text] [Related]
28. Focal and segmental glomerulosclerosis and porteinuria associated with unilateral renal agenesis. Kiprov DD; Colvin RB; McCluskey RT Lab Invest; 1982 Mar; 46(3):275-81. PubMed ID: 7062725 [TBL] [Abstract][Full Text] [Related]
29. An unusual interpodocyte cell junction and its appearance in a transplant graft kidney. Harrison DJ; Jenkins D; Dick J J Clin Pathol; 1988 Feb; 41(2):155-7. PubMed ID: 3280606 [TBL] [Abstract][Full Text] [Related]
30. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Zimmerman SW Clin Nephrol; 1984 Jul; 22(1):32-8. PubMed ID: 6383672 [TBL] [Abstract][Full Text] [Related]
31. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Meyer TN; Thaiss F; Stahl RA Transpl Int; 2007 Dec; 20(12):1066-71. PubMed ID: 17887957 [TBL] [Abstract][Full Text] [Related]
32. Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation. Apeland T; Hartmann A Nephrol Dial Transplant; 2008 Jun; 23(6):2091-4. PubMed ID: 18319357 [No Abstract] [Full Text] [Related]
33. [Course of recurrence of focal and segmental glomerulosclerosis after renal transplantation]. David Neto E; Pinto D; Tironi CA; Novelino CM; Okay Y; Saldanha LB; Arap S AMB Rev Assoc Med Bras; 1986; 32(7-8):127-30. PubMed ID: 3550920 [No Abstract] [Full Text] [Related]
34. Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis in a Child With Heterozygous Mutations in NPHS1 and NPHS2. Battelino N; Arnol M; Kandus A; Ponikvar R; Novljan G Ther Apher Dial; 2016 Jun; 20(3):312-7. PubMed ID: 27312921 [TBL] [Abstract][Full Text] [Related]
35. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Straatmann C; Kallash M; Killackey M; Iorember F; Aviles D; Bamgbola O; Carson T; Florman S; Vehaskari MV Pediatr Transplant; 2014 Feb; 18(1):29-34. PubMed ID: 24266922 [TBL] [Abstract][Full Text] [Related]
36. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient. Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697 [TBL] [Abstract][Full Text] [Related]
37. Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence. Chikamoto H; Hattori M; Kuroda N; Kajiho Y; Matsumura H; Fujii H; Ishizuka K; Hisano M; Akioka Y; Nozu K; Kaito H; Shimizu M Pediatr Transplant; 2012 Nov; 16(7):E286-90. PubMed ID: 22129369 [TBL] [Abstract][Full Text] [Related]
38. Focal glomerulosclerosis--another familial renal disease? Walker R; Bailey RR; Lynn KL; Burry AF N Z Med J; 1982 Oct; 95(717):686-8. PubMed ID: 6959017 [TBL] [Abstract][Full Text] [Related]
39. Renal failure in a living-related kidney donor: case report and review of the literature. Said R; Soyannwo M Am J Nephrol; 1996; 16(4):334-8. PubMed ID: 8739288 [TBL] [Abstract][Full Text] [Related]
40. Spontaneous remission of post-transplant recurrent focal and segmental glomerulosclerosis. Saeed B; Mazloum H; Askar M Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1219-22. PubMed ID: 22089787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]